21 May 2026
New evidence in coronary physiology for microvascular assessment
Session comprising selected EuroPCR 2026 late-breaking trials submissions
Anchorperson:
A. Lansky
Spokesperson:
C. Berry
Summary
This session highlights new evidence in coronary physiology related to microvascular assessment. Topics include endothelial dysfunction in angina with non-obstructive arteries, the prognostic value of microvascular resistance metrics, natural history studies, and trials aimed at standardizing management of microvascular dysfunction.